On August 21, Fulbright IP attorney Christopher Kindel presented at the Austin Intellectual Property Law Association luncheon.
Discussing “From Keywords to Naked Licensing,” Kindel gave an update on notable trademark law developments and trends.
To view his presentation, visit the
The U.S. Patent and Trademark Office (“USPTO”) is considering moving up the initial period for filing an Affidavit/Declaration of Use or Excusable Nonuse under Section 8 and Section 71 of the Trademark Act.
The new deadline would fall between the
Branding and promoting your goods properly can sometimes result in state tax savings, as United Parcel Service (“UPS”) recently demonstrated in a case involving the New York State Tax Law. See Slip Opinion (Aug. 16, 2012).
The case involved $3
Creative Commons, a “global nonprofit organization dedicated to the sharing and reusing of creativity and knowledge through free legal tools,” has published the second draft of its Creative Commons licenses (the “CC Suite”), dubbed “4.0.” The CC Suite is
Earlier this month it was reported that Microsoft would abandon the “Metro” brand to describe the tile-driven user interface on its Windows Phone and upcoming Windows 8 operating systems. Online tech journals, The Verge and Ars Technica, which helped
Congressmen Peter DeFazio (D-Oregon) and Jason Chaffetz (R-Utah) have introduced the SHIELD Act (Saving High-Tech Innovators from Egregious Legal Disputes, H.R. 6245) to combat the perceived threat of non-practicing entities (NPEs) to American innovation.
Specifically, the Act would allow a
To combat the continuing problem brand owners and the public have with counterfeit trademarks, Congress has enacted two new pieces of legislation.
First, the National Defense Authorization Act (“NDAA”) was signed in December 2011 and went into effect earlier this
As eCommerce accounts for an ever-growing share of retail sales, rogue websites have become a special concern for brand owners seeking to protect their valuable intellectual property from counterfeiters and others seeking a “free ride” on the brand’s goodwill.
Neurim Pharmaceuticals Ltd. was entitled to a supplementary protection certificate (SPC), which provide additional patent